INTRODUCTION

MATERIALS AND METHODS
Patient population
![]() | Fig. 1.Flow chart of the process for selecting eligible patients for present study. RA : rheumatoid arthritis, OPD : out patient department, HYMC : Hanyang University Medical Center, WNL : with in normal limit, Ant. : anterior, ADS : atlantodental subluxation, VS : vertical subluxation, MRI : magnetic resonance imaging, CT : computed tomography, AAS : atlantoaxial subluxation, pVD : pathologic vertical dislocation, BI : basilar invagination, SAS : subaxial subluxation. |
Analysis of cervical CT and MRI
Measurement of radiologic morphologic parameters
Criteria of atlantoaxial subluxation, pathologic vertical dislocation, and basilar invagination
Hand X-ray analysis
Medical history review
Statistical analysis

RESULTS
Table 1.
Normal | VD | BI | p-value (CC) | |
---|---|---|---|---|
Total patients | 161 (66.5) | 58 (24.0) | 23 (9.5) | |
Sex (female) | 131 (81.4) | 53 (91.4) | 22 (95.7) | 0.018 (0.152) |
Age (years) | 56.14±12.81 | 57.31±11.45 | 58.74±12.70 | 0.422 (0.052) |
ADI | 2.79±1.81 | 3.36±2.21 | 4.67±3.02 | 0.004 (0.183) |
PADI | 16.42±3.09 | 15.66±2.87 | 14.69±2.66 | 0.008 (-0.170) |
Power's ratio | 0.70±0.07 | 0.70±0.77 | 0.75±0.10 | 0.041 (0.132) |
McR | -5.40±1.48 | -1.35±1.14 | 3.70±2.33 | 0.000 (0.832) |
BDI | 6.66±1.94 | 3.82±2.27 | 4.80±1.76 | 0.000 (-0.462) |
BAI | 7.47±4.46 | 8.55±3.44 | 12.25±4.09 | 0.000 (0.321) |
Bony erosion | 54 (33.5) | 33 (43.1) | 30 (87.0) | 0.000 (0.327) |
Pannus formation | 39 (24.2) | 16 (27.6) | 6 (26.1) | 0.645 (0.030) |
CMJ compression | 18 (11.2) | 10 (17.2) | 18 (78.3) | 0.000 (0.358) |
C12 fixation | 20 (12.4) | 15 (25.9) | 10 (43.5) | 0.000 (0.241) |
AAS | 61 (62.1) | 37 (63.8) | 19 (82.6) | 0.000 (0.308) |
SAS | 13 (8.1) | 9 (15.5) | 11 (47.8) | 0.000 (0.269) |
Wrist Jt. erosion (Uni/Bi) | 18/48 (12.5/33.3) | 8/33 (15.7/64.7) | 0/20 (0/90.9) | 0.000 (0.402) |
Finger deformity | 28 (19.4) | 22 (42.3) | 13 (59.1) | 0.000 (0.304) |
Steroid | 128 (20.5) | 46 (20.7) | 20 (87.0) | 0.619 (0.032) |
DMARDs | 120 (74.5) | 50 (86.2) | 22 (95.7) | 0.006 (0.176) |
Immunosupressants | 126 (78.3) | 47 (81.0) | 20 (87.0) | 0.365 (0.058) |
Biologic drugs | 28 (17.4) | 9 (15.5) | 4 (17.4) | 0.826 (-0.014) |
ESR* | 86 (54.1) | 47 (81) | 18 (78.3) | 0.000 (0.249) |
CRP* | 80 (50.3) | 41 (70.7) | 18 (78.3) | 0.000 (0.219) |
Anti-CCP antibody* | 89 (84.8) | 30 (75.0) | 12 (100) | 0.781 (-0.022) |
RF* | 108 (83.7) | 42 (80.8) | 15 (75) | 0.369 (-0.064) |
VS : vertical subluxation, VD : vertical dislocation, BI : basilar invagination, CC : correlation coefficient, ADI : atlantodental interval, PADI : posterior-atlantodental interval, McR : McRae’s line and the tip of odontoid process of the axis, BDI : basin-dental interval, BAI : basin-posterior axial line interval, CMJ : cervicomedullary junction, AAS : atlantoaxial subluxation, SAS : subaxial subluxation, Jt. : joint, Uni : unilateral, Bi : bilateral, DMARDs : disease-modifying antirheumatic drugs, ESR : erythrocyte sedimentation rate, CRP : c-reactive protein, CCP : cyclic citrullinated peptide, RF : rheumatoid factor
Table 2.
Normal | AAS | p-value (CC) | |
---|---|---|---|
Total patients | 125 (51.7) | 117 (48.3) | |
Sex (female) | 100 (80) | 106 (90.6) | 0.021 (0.149) |
Age (years) | 56.73±12.28 | 56.60±12.71 | 0.912 (0.007) |
ADI | 1.70±0.55 | 4.61±2.14 | 0.000 (0.731) |
PADI | 17.16±2.38 | 24.92±3.24 | 0.000 (-0.398) |
Power's ratio | 0.70±0.07 | 0.71±0.08 | 0.281 (0.070) |
McR | -4.55±2.70 | -2.51±3.51 | 0.000 (0.317) |
BDI | 5.73±2.11 | 5.88±2.97 | 0.779 (0.018) |
BAI | 6.11±2.42 | 10.39±4.94 | 0.000 (0.578) |
Bony erosion | 31 (24.8) | 76 (65.0) | 0.000 (0.404) |
Pannus formation | 20 (16.0) | 41 (35.0) | 0.001 (0.219) |
CMJ compression | 3 (2.4) | 43 (36.8) | 0.000 (0.438) |
C12 fixation | 9 (7.2) | 36 (30.8) | 0.000 (0.303) |
SAS | 12 (9.6) | 21 (17.9) | 0.084 (0.112) |
Steroid | 102 (81.6) | 92 (78.6) | 0.565 (-0.037) |
DMARDs | 99 (79.2) | 93 (79.5) | 0.956 (0.004) |
Immunosupressants | 92 (73.6) | 101 (86.3) | 0.004 (0.249) |
Biologic drugs | 21 (16.8) | 20 (17.1) | 0.952 (0.004) |
Wrist Jt. erosion (Uni/Bi) | 13/33 (10.4/26.4) | 13/68 (11.1/58.1) | 0.000 (0.412) |
Finger deformity | 20 (17.4) | 43 (41.7) | 0.000 (0.268) |
ESR* | 69 (56.1) | 82 (70.1) | 0.209 (0.145) |
CRP* | 67 (54.0) | 72 (62.1) | 0.025 (0.081) |
Anti-CCP antibody* | 66 (83.5) | 65 (83.3) | 0.972 (-0.003) |
RF* | 83 (83.0) | 82 (81.2) | 0.739 (-0.024) |
AAS : atlantoaxial subluxation, CC : correlation coefficient, ADI : atlantodental interval, PADI : posterior-atlantodental interval, McR : McRae’s line and the tip of odontoid process of the axis, BDI : basin-dental interval, BAI : basin-posterior axial line interval, CMJ : cervicomedullary junction, SAS : subaxial subluxation, DMARDs : disease-modifying antirheumatic drugs, Jt. : joint, Uni : unilateral, Bi : bilateral, ESR : erythrocyte sedimentation rate, CRP : c-reactive protein, CCP : cyclic citrullinated peptide, RF : rheumatoid factor
![]() | Fig. 2.ROC curve analysis was performed in radiologic morphologic parameters. Note that area under the curve of BAI is larger than that of ADI and McR, which indicates higher sensitivity and specificity. BAI : basin-posterior axial line interval, ADI : atlantodental interval, McR : McRae’s line and the tip of odontoid process of the axis, BDI : basindental interval, pADI : posterior-atlantodental interval, ROC : receiver operating characteristics. |
Table 3.
Normal | CMJ compression | p-value (CC) | |
---|---|---|---|
Total patients | 196 (81.0) | 46 (19.0) | |
Sex (female) | 163 (83.2) | 43 (93.5) | 0.077 (0.144) |
Age (years) | 56.25±12.82 | 58.43±10.78 | 0.348 (0.061) |
ADI | 2.62±1.67 | 5.17±2.54 | 0.000 (0.411) |
PADI | 16.69±2.73 | 13.47±2.94 | 0.000 (-0.404) |
Power's ratio | 0.70±0.07 | 0.73±0.10 | 0.015 (0.156) |
McR | -4.21 (2.55) | -0.80 (4.42) | 0.000 (0.309) |
BDI | 5.56±2.23 | 6.80±3.50 | 0.013 (0.159) |
BAI | 7.04±2.82 | 13.03±6.27 | 0.000 (0.502) |
Bony erosion | 72 (36.7) | 35 (76.1) | 0.000 (0.311) |
Pannus formation | 40 (20.4) | 21 (45.7) | 0.000 (0.228) |
C12 fixation | 28 (14.3) | 17 (37.0) | 0.000 (0.229) |
BI | 5 (2.6) | 18 (39.1) | 0.000 (0.489) |
AAS | 74 (37.8) | 43 (93.5) | 0.000 (0.438) |
SAS | 18 (9.2) | 15 (32.6) | 0.000 (0.268) |
Wrist Jt. Erosion (Uni/Bi) | 12/69 (12.1/39.9) | 5/22 (11.4/72.7) | 0.000 (0.279) |
finger deformity | 45 (25.9) | 18 (40.9) | 0.049 (0.133) |
Steroid | 158 (80.6) | 36 (78.3) | 0.720 (-0.023) |
DMARDs | 154 (78.6) | 38 (82.6) | 0.545 (0.039) |
Immunosuppressants | 155 (79.1) | 38 (82.6) | 0.594 (0.034) |
Biologic drugs | 33 (16.8) | 8 (17.4) | 0.928 (0.006) |
ESR* | 118 (60.8) | 33 (71.7) | 0.170 (0.089) |
CRP* | 107 (55.2) | 32 (69.6) | 0.076 (0.115) |
Anti-CCP antibody* | 103 (81.1) | 28 (93.3) | 0.106 (0.129) |
RF* | 129 (80.1) | 36 (90.0) | 0.146 (0.103) |
CMJ : cervicomedullary junction, CC : correlation coefficient, ADI : atlantodental interval, PADI : posterior-atlantodental interval, McR : McRae’s line and the tip of odontoid process of the axis, BDI : basin-dental interval, BAI : basin-posterior axial line interval, BI : basilar invagination, AAS : atlantoaxial subluxation, SAS : subaxial subluxation, Jt. : joint, Uni : unilateral, Bi : bilateral, DMARDs : disease-modifying antirheumatic drugs, ESR : erythrocyte sedimentation rate, CRP : c-reactive protein, CCP : cyclic citrullinated peptide, RF : rheumatoid factor
Table 4.

DISCUSSION
Limitations

CONCLUSION
